---
title: "Otezla (apremilast) in plaque psoriasis: Indication questions"
description: "Indication questions on Otezla (apremilast) in plaque psoriasis, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: What is Otezla approved for in plaque psoriasis? 1 question quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/otezla--plaque-psoriasis/indication"
published: "2026-11-14T00:11:41-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Otezla (apremilast) in plaque psoriasis: Indication questions

Manufacturer: Amgen Inc.  
Prescribing information: [Otezla](https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf)

Indication questions that apply to every indication of Otezla are on [Otezla (apremilast), all indications: Indication](https://www.evicenter.com/medical-information/otezla/indication).

## Indication

<a id="otezla-plaque-psoriasis-indication"></a>

### What is Otezla approved for in plaque psoriasis?

> “OTEZLA/OTEZLA XR is indicated for the treatment of adult patients with plaque psoriasis who are 
> candidates for phototherapy or systemic therapy. 
>
> OTEZLA is indicated for the treatment of pediatric patients 6 years of age and older and weighing at least 
> 20 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. 
>
> OTEZLA XR is indicated for the treatment of pediatric patients 6 years of age and older and weighing at 
> least 50 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic 
> therapy.”

Source: [OTEZLA: Prescribing information, page 3, captured 2026-11-13](https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf#page=3)

## Related pages
- [Medical information: Otezla (apremilast): Plaque psoriasis](https://www.evicenter.com/medical-information/otezla--plaque-psoriasis)
- [Clinical trials](https://www.evicenter.com/medical-information/otezla--plaque-psoriasis/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/otezla--plaque-psoriasis/safety)
- [Specific populations](https://www.evicenter.com/medical-information/otezla--plaque-psoriasis/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/otezla--plaque-psoriasis/dosing-and-administration)
